Neurovascular Dysregulation During Exercise in ME/CFS and Long COVID
Location
Ft. Lauderdale, Florida
Start Date
1-11-2024 12:30 PM
End Date
1-11-2024 2:00 PM
COinS
Nov 1st, 12:30 PM
Nov 1st, 2:00 PM
Neurovascular Dysregulation During Exercise in ME/CFS and Long COVID
Ft. Lauderdale, Florida
Author Bio
Dr. David Systrom is a member of the Brigham and Women’s Hospital pulmonary and critical care faculty and Assistant Professor of Medicine at Harvard Medical School where he directs the Dyspnea Clinic and the Advanced Cardiopulmonary Exercise Testing Program. He has been on the Harvard faculty for over 35 years during which time he has received NIH, AHA, Department of Defense, Dysautonomia International and OMF funding to study various forms of exercise intolerance. Over the past five years, he has used invasive cardiopulmonary exercise testing to investigate mechanisms underlying fatigue, shortness of breath and orthostatic intolerance in ME/CFS and PASC. His recent work suggests commonality between the two, in particular neurovascular dysregulation and related hyperventilation underlying symptoms during exercise. He is the Principal Investigator of an ongoing $8 million study of limb skeletal muscle mitochondrial dysfunction and just completed the first ever randomized clinical trial pyridostigmine, both in ME/CFS.